OM
Opaleye Management’s TELA Bio TELA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-750,000
| Closed | -$6M | – | 51 |
|
|
2023
Q3 | $6M | Sell |
750,000
-830,000
| -53% | -$6.64M | 1.95% | 13 |
|
|
2023
Q2 | $16M | Sell |
1,580,000
-492,813
| -24% | -$4.99M | 3.83% | 4 |
|
|
2023
Q1 | $22.1M | Hold |
2,072,813
| – | – | 6.61% | 3 |
|
|
2022
Q4 | $23.8M | Buy |
2,072,813
+36,262
| +2% | +$417K | 8.29% | 2 |
|
|
2022
Q3 | $17.4M | Buy |
2,036,551
+393,184
| +24% | +$3.35M | 7.17% | 4 |
|
|
2022
Q2 | $11.5M | Buy |
1,643,367
+1,166,367
| +245% | +$8.18M | 5.19% | 6 |
|
|
2022
Q1 | $5.55M | Buy |
477,000
+27,133
| +6% | +$316K | 1.72% | 19 |
|
|
2021
Q4 | $5.76M | Buy |
449,867
+6,668
| +2% | +$85.3K | 1.22% | 26 |
|
|
2021
Q3 | $6.05M | Buy |
443,199
+2,734
| +0.6% | +$37.3K | 1.13% | 27 |
|
|
2021
Q2 | $7.1M | Buy |
440,465
+75,465
| +21% | +$1.22M | 1.18% | 28 |
|
|
2021
Q1 | $5.44M | Hold |
365,000
| – | – | 0.8% | 36 |
|
|
2020
Q4 | $5.49M | Buy |
365,000
+2,926
| +0.8% | +$44K | 0.72% | 37 |
|
|
2020
Q3 | $5.99M | Buy |
362,074
+112,074
| +45% | +$1.85M | 1.17% | 31 |
|
|
2020
Q2 | $3.24M | Buy |
250,000
+169,000
| +209% | +$2.19M | 0.65% | 39 |
|
|
2020
Q1 | $633K | Sell |
81,000
-94,000
| -54% | -$735K | 0.17% | 41 |
|
|
2019
Q4 | $2.27M | Buy |
+175,000
| New | +$2.27M | 0.44% | 43 |
|